Y. Fong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Y. Fong has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Paul Jarvis
Care Sciences University of South Wales Pontypridd UK
2 shared publications D Brook
Breast Test Wales, Cardiff, Wales
1 shared publicationD. Brook
Breast Test Wales, Cardiff, Wales, UK
1 shared publicationJ Evans
Breast Test Wales, Cardiff, Wales
1 shared publicationJ Kenkre
University of South Wales, Pontypridd, Wales
1 shared publicationJ. Evans
Breast Test Wales, Cardiff, Wales, UK
1 shared publication
Latest Publications
- 1 March 2015
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 97 (2) , 137-139
The Nottingham Prognostic Index: five- and ten-year data for all-cause Survival within a Screened Population
Introduction: The Nottingham Prognostic Index (NPI) is an established prognostication tool in the management of breast cancers (BCs). Latest ten-year survival data have demonstrated an improved outlook for each NPI category and the latest UK five- and ten-year survival from BC has been reported to be 85% and 77%, respectively. We compared survival of each NPI category for BCs diagnosed within the national breast screening service in Wales (Breast Test Wales (BTW)) to the latest data, and reviewed its validity in unselected cases within a screened population. Methods: All women screened between 1998 and 2001 within BTW were included. The NPI score for each cancer was calculated using the size, nodal status, and grade of the primary tumour. Survival data (all-cause) were calculated after ten years of follow-up. Results: In the three-year screening period, 199,082 women were screened. A total of 1,712 cancers were diagnosed, and 1,546 had data available for calculating the NPI. Overall five-year and ten-year survival was 94% and 82%, respectively. Conclusions: Overall five-year and ten-year survival (all-cause) has improved even when compared with UK data for BC-specific survival. We found that the NPI remains valid for BC treatment, and that our data provide a reference for updating the all-cause survival of women diagnosed with BCs within a screened population.
- 1 March 2015
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 97 (2) , 137-139
The Nottingham Prognostic Index: five- and ten-year data for all-cause Survival within a Screened Population
Introduction: The Nottingham Prognostic Index (NPI) is an established prognostication tool in the management of breast cancers (BCs). Latest ten-year survival data have demonstrated an improved outlook for each NPI category and the latest UK five- and ten-year survival from BC has been reported to be 85% and 77%, respectively. We compared survival of each NPI category for BCs diagnosed within the national breast screening service in Wales (Breast Test Wales (BTW)) to the latest data, and reviewed its validity in unselected cases within a screened population. Methods: All women screened between 1998 and 2001 within BTW were included. The NPI score for each cancer was calculated using the size, nodal status, and grade of the primary tumour. Survival data (all-cause) were calculated after ten years of follow-up. Results: In the three-year screening period, 199,082 women were screened. A total of 1,712 cancers were diagnosed, and 1,546 had data available for calculating the NPI. Overall five-year and ten-year survival was 94% and 82%, respectively. Conclusions: Overall five-year and ten-year survival (all-cause) has improved even when compared with UK data for BC-specific survival. We found that the NPI remains valid for BC treatment, and that our data provide a reference for updating the all-cause survival of women diagnosed with BCs within a screened population.
- 1 April 2014
- Published by Elsevier in Clinical Radiology
- Vol. 69 (4) , e168-e172
The incidence and 10-year survival of interval breast cancers in Wales
- 1 April 2014
- Published by Elsevier in Clinical Radiology
- Vol. 69 (4) , e168-e172
The incidence and 10-year survival of interval breast cancers in Wales